All News #Library
Biotech
Eirgenix Signs Commercial Licensing Deal For HER2 Biosimilar
12 Nov 2025 //
PR NEWSWIRE
EirGenix`s Breast Cancer Biosimilar Receives Marketing Authorization by EC
22 Nov 2023 //
PR NEWSWIRE
EirGenix`s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1
02 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support